Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome-Reference-Cited by-同舟云学术

Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome

Published:2015-01 Issue:1 Volume:135 Page:26-30
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Braun Oscar Ö.,Bico Besim,Chaudhry Uzma,Wagner Henrik,Koul Sasha,Tydén Patrik,Scherstén Fredrik,Jovinge Stefan,Svensson Peter J.,Gustav Smith J.,van der Pals Jesper

Funder

Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Combining antiplatelet and anticoagulant therapies;Holmes;J Am Coll Cardiol,2009

2. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action;Wysowski;Arch Intern Med,2007

3. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Becker;Chest,2008

4. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology;Silber;Eur Heart J,2005

5. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines;King;J Am Coll Cardiol,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrilación auricular de <i>novo</i> en síndrome coronario agudo;Archivos de Cardiología de México;2024-04-18

2. Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention;Journal of Clinical Medicine;2022-01-20

3. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter;Russian Journal of Cardiology;2021-08-08

4. Clinical Effectiveness of Rivaroxaban in Patients With Idiopathic Pulmonary Fibrosis and Thrombosis of the Right Ventricle;Bulletin of Science and Practice;2021-01-15

5. Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention;American Journal of Cardiovascular Drugs;2020-09-08